| Walgreens #19394 | |
| 1193 Boston Neck Rd, Narragansett, Rhode Island 02882 | |
| (401) 789-5037 |
| Name | Walgreens #19394 |
|---|---|
| Organization Name | Walgreen Co |
| Location | 1193 Boston Neck Rd, Narragansett, Rhode Island 02882 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (401) 789-5037 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Researchers and clinicians from the University of Sydney and the Northern Sydney Cancer Centre are leading a world first clinical trial using a tracking system to improve prostate cancer radiotherapy treatment.
Cancer Research UK scientists are investigating whether beta-blockers hold the key to preventing breast cancer spread and improving survival. Promising early results will be presented on the eve of breast cancer awareness month at the Royal Society of Medicine.
Adverse events for patients being treated for heart attack and heart failure have declined, according to a new study published in the January 23 issue of the New England Journal of Medicine. However, the analysis funded by the Agency for Healthcare Research and Quality found that there has not been a significant decrease in adverse events for patients being treated for pneumonia and those who are recovering from surgery.
While swearing is often a common response to pain, Richard Stephens and his colleagues, John Atkins and Andrew Kingston, were surprised to discover that no links had been established between swearing and the actual experience of physical pain.
Drug company Pfizer has announced it has submitted a New Drug Application (NDA) for its cancer drug Sutent, to the U.S. Food and Drug Administration (FDA).
› Verified 9 days ago
| NPI Number | 1104349976 |
| Organization Name | WALGREEN CO |
| Doing Business As | WALGREENS #19394 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1193 Boston Neck Rd, Narragansett, RI 02882 |
| Phone Number | 401-789-5037 |
News Archive
Researchers and clinicians from the University of Sydney and the Northern Sydney Cancer Centre are leading a world first clinical trial using a tracking system to improve prostate cancer radiotherapy treatment.
Cancer Research UK scientists are investigating whether beta-blockers hold the key to preventing breast cancer spread and improving survival. Promising early results will be presented on the eve of breast cancer awareness month at the Royal Society of Medicine.
Adverse events for patients being treated for heart attack and heart failure have declined, according to a new study published in the January 23 issue of the New England Journal of Medicine. However, the analysis funded by the Agency for Healthcare Research and Quality found that there has not been a significant decrease in adverse events for patients being treated for pneumonia and those who are recovering from surgery.
While swearing is often a common response to pain, Richard Stephens and his colleagues, John Atkins and Andrew Kingston, were surprised to discover that no links had been established between swearing and the actual experience of physical pain.
Drug company Pfizer has announced it has submitted a New Drug Application (NDA) for its cancer drug Sutent, to the U.S. Food and Drug Administration (FDA).
› Verified 9 days ago
| NPI Number | 1154709889 |
| Organization Name | RITE AID |
| Type | Community/Retail Pharmacy |
| Address | 1193 Boston Neck Rd, Narragansett, RI 02882 |
| Phone Number | 401-789-5037 |
News Archive
Researchers and clinicians from the University of Sydney and the Northern Sydney Cancer Centre are leading a world first clinical trial using a tracking system to improve prostate cancer radiotherapy treatment.
Cancer Research UK scientists are investigating whether beta-blockers hold the key to preventing breast cancer spread and improving survival. Promising early results will be presented on the eve of breast cancer awareness month at the Royal Society of Medicine.
Adverse events for patients being treated for heart attack and heart failure have declined, according to a new study published in the January 23 issue of the New England Journal of Medicine. However, the analysis funded by the Agency for Healthcare Research and Quality found that there has not been a significant decrease in adverse events for patients being treated for pneumonia and those who are recovering from surgery.
While swearing is often a common response to pain, Richard Stephens and his colleagues, John Atkins and Andrew Kingston, were surprised to discover that no links had been established between swearing and the actual experience of physical pain.
Drug company Pfizer has announced it has submitted a New Drug Application (NDA) for its cancer drug Sutent, to the U.S. Food and Drug Administration (FDA).
› Verified 9 days ago
News Archive
Researchers and clinicians from the University of Sydney and the Northern Sydney Cancer Centre are leading a world first clinical trial using a tracking system to improve prostate cancer radiotherapy treatment.
Cancer Research UK scientists are investigating whether beta-blockers hold the key to preventing breast cancer spread and improving survival. Promising early results will be presented on the eve of breast cancer awareness month at the Royal Society of Medicine.
Adverse events for patients being treated for heart attack and heart failure have declined, according to a new study published in the January 23 issue of the New England Journal of Medicine. However, the analysis funded by the Agency for Healthcare Research and Quality found that there has not been a significant decrease in adverse events for patients being treated for pneumonia and those who are recovering from surgery.
While swearing is often a common response to pain, Richard Stephens and his colleagues, John Atkins and Andrew Kingston, were surprised to discover that no links had been established between swearing and the actual experience of physical pain.
Drug company Pfizer has announced it has submitted a New Drug Application (NDA) for its cancer drug Sutent, to the U.S. Food and Drug Administration (FDA).
› Verified 9 days ago
Cvs Pharmacy #00409 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1123 Boston Neck Rd, Narragansett, Rhode Island 02882 Phone: (401) 783-1753 | |
Walgreens #19189 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 20 Woodruff Ave, Narragansett, Rhode Island 02882 Phone: (401) 792-7179 | |
Stop & Shop Pharmacy #718 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 91 Point Judith Rd, Narragansett, Rhode Island 02882 Phone: (401) 783-7768 | |
Walgreens #19394 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1193 Boston Neck Rd, Narragansett, Rhode Island 02882 Phone: (401) 789-5037 | |
National Surgical Supply Type: DME Supplier - Oxygen Equipment & Supplies Location: 14 Woodruff Ave, Narragansett, Rhode Island 02882 Phone: (401) 783-1850 |